New Delhi, April 9 (IANS) Despite mounting risks from rising crude, a weaker rupee, India’s growth momentum continues to remain robust, with Q3 GDP expanding by 7.8 per cent and full-year FY26 growth projected at 7.6 per cent, healthy private consumption growth and manufacturing push, a report said on Thursday.The recent market corrections created a favourable valuation backdrop, with the Nifty trading at a 5.6 per cent discount to its five-year average PE, enhancing the medium-term risk-rewar…
Latest quality News & Updates
New Delhi, March 30 (IANS) Electronics and IT Minister Ashwini Vaishnaw on Monday made it clear to industry players participating in the Electronics Components Manufacturing Scheme (ECMS) that companies must invest meaningfully in designing products in India if they wish to continue receiving government support.Addressing a press conference here, he said that incentives and support will be closely tied to demonstrable progress in building indigenous design, quality, and engineering capabilities …
New Delhi, March 21 (IANS) Union Minister Dr Jitendra Singh on Saturday said that India is steadily evolving into a robust pharma economy, which could help as a significant contributor to the country’s overall GDP.During his address at a ‘Healthcare Summit’ here, the minister stated the nation’s pharmaceutical, medtech and manufacturing ecosystem is positioning the country as a key global manufacturing hub — particularly in high-quality, affordable healthcare solutions.The minister said that …
New Delhi, Jan 25 (IANS) Prime Minister Narendra Modi on Sunday referred to the ‘2026 is the new 2016’ trend on social media and shared his memories of a decade ago when the government launched the Startup India programme, calling it “very important” for the youth and the future of the country. He called the youth the “heroes” of the “amazing journey” of the Startup India programme and said that now, Indian startups are working in every sector.Addressing the 130th episode of his monthly radio pr…
New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…